Financial results - HAPENCIUC MED SRL

Financial Summary - Hapenciuc Med Srl
Unique identification code: 21417451
Registration number: J33/499/2007
Nace: 8621
Sales - Ron
105.813
Net Profit - Ron
45.805
Employee
3
The most important financial indicators for the company Hapenciuc Med Srl - Unique Identification Number 21417451: sales in 2023 was 105.813 euro, registering a net profit of 45.805 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Hapenciuc Med Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 43.413 45.721 45.967 57.213 62.261 69.988 70.296 81.397 80.879 105.813
Total Income - EUR 43.987 45.746 45.990 57.290 62.273 69.988 73.432 81.672 86.591 114.566
Total Expenses - EUR 34.180 33.656 36.526 47.988 49.860 47.389 54.636 46.418 50.967 67.844
Gross Profit/Loss - EUR 9.806 12.091 9.463 9.301 12.413 22.599 18.796 35.253 35.625 46.723
Net Profit/Loss - EUR 8.487 10.718 9.004 8.597 11.782 21.928 18.143 34.586 35.082 45.805
Employees 4 4 4 4 3 3 3 2 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 31.2%, from 80.879 euro in the year 2022, to 105.813 euro in 2023. The Net Profit increased by 10.830 euro, from 35.082 euro in 2022, to 45.805 in the last year.

Check the financial reports for the company - Hapenciuc Med Srl

Rating financiar

Financial Rating -
Hapenciuc Med Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Hapenciuc Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Hapenciuc Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Hapenciuc Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Hapenciuc Med Srl - CUI 21417451

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 14.070 9.104 4.175 17.762 12.146 7.458 4.860 -503 -1.050 19.287
Current Assets 80.266 94.194 40.395 27.938 52.446 45.438 66.078 74.001 98.754 125.032
Inventories 658 664 657 676 98 0 0 0 0 14
Receivables 3.876 3.333 5.654 5.862 6.429 8.662 3.527 5.305 4.983 10.509
Cash 75.731 90.198 34.084 21.399 45.918 36.776 62.552 68.696 93.771 114.509
Shareholders Funds 83.469 94.883 36.116 44.101 55.074 44.368 61.670 70.631 39.521 64.991
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 10.867 8.415 8.454 1.599 9.519 8.529 9.268 2.868 58.183 79.329
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 125.032 euro in 2023 which includes Inventories of 14 euro, Receivables of 10.509 euro and cash availability of 114.509 euro.
The company's Equity was valued at 64.991 euro, while total Liabilities amounted to 79.329 euro. Equity increased by 25.589 euro, from 39.521 euro in 2022, to 64.991 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Hapenciuc Med Srl

Comments - Hapenciuc Med Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.